Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human-Reference-Cited by-同舟云学术

Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human

Published:2017-12-12 Issue:4 Volume:24 Page:766-776
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Aerts Joachim G.J.V.,de Goeje Pauline L.,Cornelissen Robin,Kaijen-Lambers Margaretha E.H.,Bezemer Koen,van der Leest Cor H.,Mahaweni Niken M.,Kunert André,Eskens Ferry A.L.M.,Waasdorp Cynthia,Braakman Eric,van der Holt Bronno,Vulto Arnold G.,Hendriks Rudi W.,Hegmans Joost P.J.J.,Hoogsteden Henk C.

Funder

KWF Kankerbestrijding (Dutch Cancer Society)

ZonMw (Netherlands Organisation for Health Research and Development)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic Cell–Based Immunotherapy in Patients With Resected Pancreatic Cancer;Journal of Clinical Oncology;2024-09-10

2. Future of Dendritic Cell–Based Approaches in Pancreatic Cancer;Journal of Clinical Oncology;2024-09-10

3. Boosting immunotherapy efficacy: Empowering the Potency of Dendritic cells loaded with breast cancer lysates through CTLA-4 suppression;Heliyon;2024-09

4. Refreshing the mesothelioma catalogue: tailoring cellular therapy in the DENIM trial;The Lancet Oncology;2024-07

5. Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 study;The Lancet Oncology;2024-07